| Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug H Wu, E Esteve, V Tremaroli, MT Khan, R Caesar, L Mannerås-Holm, ... Nature medicine 23 (7), 850-858, 2017 | 1526 | 2017 |
| The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study H Wu, V Tremaroli, C Schmidt, A Lundqvist, LM Olsson, M Krämer, ... Cell metabolism 32 (3), 379-390. e3, 2020 | 370 | 2020 |
| Developmental trajectory of the healthy human gut microbiota during the first 5 years of life J Roswall, LM Olsson, P Kovatcheva-Datchary, S Nilsson, V Tremaroli, ... Cell host & microbe 29 (5), 765-776. e3, 2021 | 326 | 2021 |
| Combinatorial, additive and dose-dependent drug–microbiome associations SK Forslund, R Chakaroun, M Zimmermann-Kogadeeva, L Markó, ... Nature 600 (7889), 500-505, 2021 | 159 | 2021 |
| Microbiome and metabolome features of the cardiometabolic disease spectrum S Fromentin, SK Forslund, K Chechi, J Aron-Wisnewsky, R Chakaroun, ... Nature medicine 28 (2), 303-314, 2022 | 144 | 2022 |
| Dynamics of the normal gut microbiota: a longitudinal one-year population study in Sweden LM Olsson, F Boulund, S Nilsson, MT Khan, A Gummesson, L Fagerberg, ... Cell host & microbe 30 (5), 726-739. e3, 2022 | 112 | 2022 |
| Integration of molecular profiles in a longitudinal wellness profiling cohort A Tebani, A Gummesson, W Zhong, IS Koistinen, T Lakshmikanth, ... Nature communications 11 (1), 4487, 2020 | 94 | 2020 |
| Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health LM Olsson, C Poitou, V Tremaroli, M Coupaye, J Aron-Wisnewsky, ... Gut 69 (7), 1229-1238, 2020 | 37 | 2020 |
| Development and dynamics of the normal gut microbiota L Olsson | | 2020 |
